This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Salesforce.com (CRM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $183.79, moving +0.44% from the previous trading session.
Microsoft (MSFT) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Microsoft (MSFT) delivered earnings and revenue surprises of -2.19% and 0.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights Visa, Abbott Laboratories, Salesforce, Wells Fargo and Centene
by Zacks Equity Research
Visa, Abbott Laboratories, Salesforce, Wells Fargo and Centene are included in this Analyst Blog.
Top Research Reports for Visa, Abbott & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Abbott Laboratories (ABT) and Salesforce, Inc. (CRM).
Stock Market News for Jul 21, 2022
by Zacks Equity Research
U.S. stocks closed higher on Wednesday, driven by a rally in tech stocks, while investors remained wary about surging inflation and tried to assess how much interest rate the Fed would hike in its upcoming meeting.
6 Reasons Why You Should Invest in Salesforce (CRM) Stock Now
by Zacks Equity Research
Salesforce (CRM) is one stock that investors can consider adding to their portfolio amid the current stock market volatilities.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $161.04 in the latest trading session, marking a -1.5% move from the prior day.
Stock Market News for Jul 13, 2022
by Zacks Equity Research
U.S. stocks tumbled on Tuesday amid recession worries in a late-session dive.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $175.50 in the latest trading session, marking a -0.65% move from the prior day.
Should You Invest in the iShares Expanded TechSoftware Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $168.20 in the latest trading session, marking a +1.91% move from the prior day.
Salesforce.com (CRM) Down 3.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock Salesforce Inc. (CRM) a Buy Now?
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Reflections from Sintra Portugal: Global Week Ahead
by John Blank
The Fed has Jackson Hole, but the ECB has Sintra, its very own central bank forum in the foothills of Portugal's Sintra Mountains.
Zacks Earnings Trends Highlights: Lennar, Microsoft, Salesforce, Target and Walmart
by Zacks Equity Research
Lennar, Microsoft, Salesforce, Target and Walmart have been highlighted in this Earnings Trend article.
Will Earnings Estimates Finally Come Down?
by Sheraz Mian
Part of the uncertainty in the market at present is related to how earnings estimates should evolve in an aggressive Fed tightening cycle. The market has a sense of what should happen to earnings estimates, but it isn't seeing much of that just yet.
Will Earnings Estimates Finally Come Down?
by Sheraz Mian
Part of the uncertainty in the market at present is related to how earnings estimates should evolve in an aggressive Fed tightening cycle. The market has a sense of what should happen to earnings estimates, but it isn't seeing much of that just yet.
3 Stocks With Robust Cloud Computing Operations
by Derek Lewis
Cloud computing segments have primarily enjoyed stellar performances and strong revenue growth.
Is Most-Watched Stock Salesforce Inc. (CRM) Worth Betting on Now?
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Looking Ahead to the Q2 Earnings Season as the Fed Hikes Rates
by Sheraz Mian
Excluding the hefty contribution from the Energy sector, total Q2 earnings for the rest of the S&P 500 index are expected to be down -5.1% on +7.4% higher revenues...
Looking Ahead to the Q2 Earnings Season as the Fed Hikes Rates
by Sheraz Mian
Excluding the hefty contribution from the Energy sector, total Q2 earnings for the rest of the S&P 500 index are expected to be down -5.1% on +7.4% higher revenues...
Company News for Jun 14, 2022
by Zacks Equity Research
Companies In The News Are: CRM, AXP, NCLH, AAL.
The Zacks Analyst Blog Highlights Novo Nordisk, Toyota Motor, Salesforce, Abbott Laboratories, Raytheon Technologies, and Equinor
by Zacks Equity Research
Novo Nordisk, Toyota Motor, Salesforce, Abbott Laboratories, Raytheon Technologies, and Equinor are part of Zacks top Analyst Blog.